US20170209647A1 - Medicament delivery device - Google Patents

Abstract

The present invention relates to a medicament delivery device comprising a drive means configured to act on a medicament container for expelling a medicament; a holding means configured to hold said drive means in a pre-tensioned state; an activation means configured to interact with said holding means for releasing said drive means from the pre-tensioned state; wherein the device further comprises feedback means configured to interact both with said holding means and with said drive means for generating an audible and/or tactile and/or visual signal indicating that the medicament has been completely expelled.

Description

CROSS REFERENCE TO RELATED APPLICATIONS
• The present application is a continuation of U.S. patent application Ser. No. 13/650,708, filed Oct. 12, 2012, which is a continuation of U.S. patent application Ser. No. 13/636,241 filed Oct. 12, 2012, now U.S. Pat. No. 9,199,038, which is a U.S. National Phase Application pursuant to 35 U.S.C. §371 of International Application No. PCT/SE2011/050236 filed Mar. 23, 2011, which claims priority to Swedish Patent Application No. 1050307-6 filed on Mar. 31, 2010 and U.S. Patent Application No. 61/319,453 filed Mar. 31, 2010. The entire disclosure contents of these applications are herewith incorporated by reference into the present application.
FIELD OF INVENTION
• The present invention relates to a medicament delivery device and in particular to an improved, more user-friendly, automatic medicament delivery device providing an audible, tactile or visual confirmation to a user when an injection has been made.
BACKGROUND
• Many medicament delivery devices are developed for self-administration, i.e. a user performs the medicament delivery her-, or himself. This requires a medicament delivery device which is as safe to use and as easy to handle as possible. In order to meet these requirements, the risk of human errors must be minimized, the number of actions needed to be performed in order to receive a dose need to be reduced and the device must be intuitive and ergonomic to use. Thus, in order to minimize the risk of human errors, it is desirable to have the device as pre-assembled as possible.
• Document EP 1349590 B describes an injector having a number of features that facilitate the handling of the injector. The penetration and injection is performed manually by simply pressing the proximal end of a needle shield against the delivery area, causing the shield to move in a distal direction, enabling the needle to penetrate the injection area and thereafter initialize the injection process. When the injection is performed the injector is withdrawn whereby a needle shield extracts around the needle in a locked way.
• Other aspects of injectors are the human aspect of handling the injector regarding how it is held during operation. a general aim is to have the patient holding the injector in an ergonomic way that may permit the penetration and injection in different locations on the body, such as around the waist and also on the backside of the waist and/or in the buttocks of the patient. Sometimes the patient does not see the injector at those locations and need to be able to hold the injector without having to change grip. By removing the action of pushing a button or the like, the patient is free to hold the device as he desires and feels comfortable.
• It is considered important for the patient to receive a confirmation that the injection has been made, in particular in instances when an injector is used where the patient does not see the injector, e.g. such as around the waist and also on the backside of the waist and/or in the buttocks of the patient.
SUMMARY
• The object of the present invention is to provide a medicament delivery device that is reliable and easy to use when handling and activating, this is achieved by a medicament delivery device comprising a drive means configured to act on a medicament container for expelling a medicament; a holding means configured to hold said drive means in a pre-tensioned state; an activation means configured to interact with said holding means for releasing said drive means from the pre-tensioned state; wherein the device further comprises feedback means configured to interact both with said holding means and with said drive means for generating an audible and/or tactile and/or visual signal indicating that the medicament has been completely expelled.
• According to another aspect of the invention the device further comprises a tubular housing having a proximal end and an opposite distal end.
• According to a further aspect of the invention the activation means is a tubular activation member slidably and coaxially arranged in relation to the tubular housing.
• According to yet another aspect of the invention the device further comprises a container holder coaxially arranged within the tubular activation member and fixedly attached to the tubular housing.
• According to yet a further aspect of the invention the medicament container is arranged within said container holder and wherein said medicament container comprises a pre-determined volume of medicament, a slidable stopper and a delivery member.
• According to yet an aspect of the invention the drive means comprises a plunger rod and a first resilient member which is pre-tensioned arranged within the plunger rod and wherein said plunger rod is arranged to be in contact with the slidable stopper within the medicament container.
• According to another aspect of the invention the holding means are a tubular extension part fixedly connected to the distal end of the tubular housing and a tubular operation member which is interactively connected both to the tubular extension part and to the tubular activation member, such that when said tubular activation member is pressed against a delivery site said tubular operation member is rotated in relation to said tubular extension part whereby said drive means are released from the pre-tensioned state for exerting a pressure on the slidable stopper and thereby expelling the medicament.
• According to a further aspect of the invention the feedback means is a longitudinally extending signal generating member interactively connected to said tubular extension part and to said drive means, such that when the plunger rod is completely released from the tubular extension part and the longitudinally extending signal generating member, the longitudinally extending signal generating member is released from said tubular extension part and displaced distally by a remaining force of the first resilient member for generating an audible and/or tactile and/or visual signal indicating that the medicament has been completely expelled.
• According to a still further aspect of the invention, the tubular operation member comprises a first co-acting means interactively connected to a corresponding first co-acting means of the tubular activation member and a second co-acting means interactively connected to a corresponding second co-acting means of the tubular extension part; the plunger rod comprises a releasable engaging means interactively connected to the corresponding second co-acting means of the tubular extension part and a proximal end wall being in contact with the slidable stopper; the longitudinally extending signal generating member is releasable arranged on an inner surface of the tubular extension part; and wherein the first resilient member has a first end abutting the proximal end wall of the plunger rod and a second end abutting a transversal wall of the signal generating member.
• According to another aspect of the invention, the second co-acting means comprises a groove on an inner surface of the tubular operation member and the corresponding second co-acting means of the tubular extension part comprises a resilient tongue, having a radial inward protrusion.
• According to a yet another aspect of the invention, the releasable engaging means comprises a groove on an outer surface of the plunger rod releasable engaged to the radial inward protrusion of the resilient tongue adapted to hold the drive means in the pre-tensioned state.
• According to a yet a further aspect of the invention, the first co-acting means comprise a groove on an outer surface of the tubular operation member and the first corresponding co-acting means comprise a radial inward extending protrusion on the distal end of the inner surface of the tubular activation member, such that the radial inward extending protrusion is adapted to be guided within the groove on an outer surface of the tubular operation member forcing the tubular operation member to rotate when the tubular activation member is distally moved, whereby the resilient tongue is flexed radial outward into a groove on the inner surface of the tubular operation member and the radial inward extended protrusion is disengaged from the groove on the outer surface of the plunger rod such that the drive means are released from the pre-tensioned state.
• According to another aspect of the invention, the signal generating member is an elongated u-shaped bracket comprising a transversal wall and two longitudinally extending flexible arms provided with angled support members extending radially outward, and wherein said support members are adapted to rest on an annular proximal end of the tubular extension part when the drive means are in the pre-tensioned state.
• According to a further aspect of the invention, the transversal wall of the U-bracket is arranged at a predetermined distance D from an inner distal surface of said tubular extension part when the drive means are in the pre-tensioned state.
• According to yet another aspect of the invention, the audible signal is generated for confirming that a medicament delivery has been performed when the distal end of the plunger rod has passed the supporting members, such that the longitudinally extending flexible arms, with the support members, are released and allowed to move in a radial inward direction, enabling the U-bracket to move the predetermined distance D in the distal direction by a remaining force exerted by said first resilient member, whereby the transversal wall of the bracket hits the inner distal surface of said tubular extension part.
• According to yet a further aspect of the invention, the transversal wall of the U-bracket comprises a distally extending protrusion and the distal surface of the tubular extension part comprises a through hole, such that when the transversal wall of the U-bracket hits the inner distal surface of said tubular extension part, the distally extending protrusion passes through the through hole and extends distally a predetermined distance over the outer surface of said tubular extension part for generating a tactile signal.
• According to another aspect of the invention, the distally extending protrusion has a bright and/or different colour than the rest of the device for generating a visual signal.
• By the term automatic medicament delivery device, is herein meant a medicament delivery device adapted to deliver a medicament without a user having to press a push button or activation member, but instead only by pressing the proximal end of the medicament delivery device against the delivery site.
• In automatic medicament delivery device it is considered, as mentioned above, important for the patient to receive a confirmation that the delivery has been made, in particular when the medicament delivery device is used where the patient does not see the medicament delivery device, e.g. such as around the waist and also on the backside of the waist and/or in the buttocks of the patient. Therefore, a signal i.e. an audible sound, and/or a tactile signal, and/or a visual signal, or a combination thereof is generated in direct temporal relationship to the physical actuation of the medicament container, in order to expel the medicament from the medicament container.
• The medicament delivery device according to the present invention presents a number of advantages. There is a high degree of functionality and automation, which remove unnecessary components and actions for delivering a medicament.
• Also an important safety aspect is met since, during withdrawal, the tubular activation member is pushed out and covers the delivery member e.g. a needle, and also locks in the extended state, thereby preventing unintentional needle sticks.
• These and other aspects of and advantages with the present invention will become apparent from the following detailed description and from the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
• In the following detailed description of the invention, reference will be made to the accompanying drawings, of which
• FIG. 1a-FIG. 1cshows perspective views of different components of the medicament delivery device.
• FIG. 2a-FIG. 2dshows perspective views of different states of the medicament delivery device.
• FIG. 3 illustrates a plunger rod and audio-tacit-visual signal generating member assembly.
• FIG. 4a-FIG. 4cillustrates the components of the audio-tacit-visual signal signal generating member-, and plunger rod assembly.
• FIG. 5 shows a perspective view of a driving means comprised in the present invention.
• FIG. 6a-FIG. 6cshows a side view of the tubular housing and the audio-tacit-visual signal generating member in operation,
• FIG. 7-FIG. 11 show side views along the longitudinal axis of the medicament delivery device according to an embodiment of the present invention, illustrating different states of an injection procedure.
DETAILED DESCRIPTION
• In the present application, when the term “distal part/end” is used, this refers to the part/end of the delivery device, or the parts/ends of the members thereof, which is/are located the furthest away from the medicament delivery site of the patient. Correspondingly, when the term “proximal part/end” is used, this refers to the part/end of the delivery device, or the parts/ends of the members thereof, which, is/are located closest to the medicament delivery site of the patient.
• FIG. 1aillustrates, in perspective, atubular housing20 of an exemplarymedicament delivery device1. Thetubular housing20 having aproximal end11 and an oppositedistal end12. Thetubular housing20 further comprises a protrusion (not illustrated) on its inner wall. The protrusion is adapted for receiving arecess36 of an activation means, such as a tubular activation member30 (seeFIG. 1b). Therecess36 of thetubular activation member30 is used for locking thetubular activation member30, inside thetubular housing20, when thetubular activation member30 is in its most proximal position, after an injection has been made. In an exemplary embodiment there are two protrusions (not illustrated), one on each side of the inner wall of thetubular housing20, and correspondingly tworecesses36 of thetubular activation member30. Thetubular housing20 further comprises acontainer holder50 which is coaxially arranged and fixedly attached within thetubular housing20 for lodging a medicament container80 (seeFIG. 1c). Themedicament injection device1 further comprises atubular extension part22, being coaxially arranged and fixedly attached to thedistal end12 of the housing preferably by aflexible tongue15 engaging with a corresponding ledge23 (seeFIG. 5) of thetubular extension part22.
• FIG. 1billustrates thetubular activation member30 of themedicament injection device1. Thetubular activation member30 having anannular contact member31 and a corresponding first co-acting means35, which in an exemplary embodiment is a protrusion. In an exemplary embodiment of the invention there are two corresponding first co-acting means35 which are used for activating themedicament delivery device1 as will be described in detail below. In the figure is in particular illustrated a guiding means34 which is adapted to cooperate with a corresponding guiding rod (not shown) at the interior of thetubular housing20, with the purpose to prevent that thetubular activation member30 may rotate in relation to thetubular housing20 and to allow thetubular activation member30 to move in the axial direction in relation to thetubular housing20. In a preferred embodiment of the invention there are two guidingmeans34 and correspondingly two guiding rods (not shown). According to an embodiment of the invention, a second resilient member24 (seeFIG. 1c), which in an exemplary embodiment is a tension spring, is arranged at the proximal end of thetubular activation member30 for moving it in a proximal direction. The cut-out/recess36 is, when themedicament injection device1 is positioned in its final position in order to prevent unintentional availability of a proximal needle end61 (seeFIG. 1c), engaging with a corresponding protrusion (not illustrated) of thetubular housing20.
• FIG. 1cillustrates the interior of themedicament delivery device1 further comprising the secondresilient member24 arranged in relation to thetubular activation member30 for moving it in a proximal direction from a non-activated position to an activated position whereby theannular contact member31 is in contact with the proximal end of thehousing20 when themedicament injection device1 is in non-activated state and whereby theannular contact member31 is at a predetermined distance from the proximal end of the housing when themedicament injection device1 is in activated state. Themedicament container80 is arranged within thecontainer holder50 and has a predetermined volume of medicament, aslidable stopper83 and a delivery member. In an exemplary embodiment of the invention themedicament container80 is a syringe provided with aneedle61 as the delivery member, however the invention should not be limited to this, other embodiments could include a medicament cartridge having amembrane82, or the like where a delivery member can be adapted. In themedicament delivery device1 is also included a tubular operation member100 (seeFIG. 5) comprising a second co-acting means101,102 interactively connected to a corresponding first co-acting means35 of the tubular activation member30 (seeFIG. 1b), drive means comprising aplunger rod90 and a firstresilient member91 arranged within the plunger rod. The plunger rod comprises a releasable engagingmeans94 as a cut-out/recess (seeFIG. 4c) interactively connected to a corresponding second co-acting means121 (seeFIG. 5) of thetubular extension part22. The firstresilient member91 is in an exemplary embodiment of the invention a tension spring. Theproximal end92 of theplunger rod90 is in contact with theslidable stopper83. The tubular operation member100 (seeFIG. 5) is rotatably and coaxially arranged on a proximal part of thetubular extension part22 between thecontainer holder50 and an annular ledge of thetubular extension part22 at the distal end of thetubular housing20.
• Together, thetubular extension part22 and thetubular operation member100 form a holding means, for holding the drive means in a pre-tensioned state prior to penetration. Upon actuation of the activation means a feedback means interacts with the holding means and the drive means to signal that a medicament has been completely expelled.
• FIG. 2a-FIG. 2dshow simplified perspective views of themedicament delivery device1, whereFIG. 2aillustrates an initial, non-activated, state of themedicament delivery device1 having acap10.FIG. 2bshows an activated state of themedicament delivery device1, where thecap10 is removed.FIG. 2cshows the penetration and injection state of themedicament delivery device1 and finallyFIG. 2dshows themedicament delivery device1 in a final locked state. With references toFIG. 2a, themedicament delivery device1 comprises thetubular housing20, having a proximal end and an opposite distal end. Themedicament injection device1 further comprises thetubular activation member30 which is slidably and coaxially arranged inside thetubular housing20 and comprises the proximalannular contact member31. Thecap10 comprises a distal end surface, abutting with the proximal end surface of theannular contact member31 of thetubular activation member30 such that when thecap10 is manually operated and detached, it allows thetubular activation member30 to be moved by the force from the second resilient member24 (FIG. 1c) from its non-activated position to its activated position.
• FIG. 2bshow themedicament delivery device1 when it is ready for use. When a user is about to perform a medicament delivery e.g. an injection he/she presses the proximal end, i.e. theannular contact member31, against the delivery site e.g. an injection site. Thetubular activation member30 is then moved in the distal direction, in relation to thetubular housing20, and during the relative movement when having a medicament delivery device as an injection device, then aneedle61 manually penetrates the skin. When thetubular activation member30 is about to reach its most distal position in relation to thetubular housing20 the medicament delivery is performed. A medicament delivery is automatically performed when thetubular activation member30, being in an activated position, is moved in a distal direction in relation to thetubular housing20, to a delivery state position, where theannular contact member31 is close to theproximal end11 of thetubular housing20.
• FIG. 2cillustrates when the delivery is made, then the user removes themedicament delivery device1 from the delivery site, thereby allowing thetubular activation member30 to move in the proximal direction in relation to thetubular housing20, by the force exerted by the secondresilient member24 and finally reaches a final state; the locked state.
• FIG. 2dillustrates themedicament delivery device1 in its final and locked state, wherein thetubular activation member30 once more is in its most proximal position, as illustrated. in this state the proximal part of thetubular activation member30 fully protects thedelivery member61 and thetubular activation member30 is also locked, by the cut-out/recesses36 (seeFIG. 1b) in the distal end of thetubular activation member30, engaging with the protrusions (not illustrated) of thetubular housing20, in the final position in order to prevent unintentional availability of thedelivery member61.
• FIG. 3 illustrates various aspects of the feedback means, such as asignal generating member110 and its implementations (see alsoFIG. 4a-FIG. 4c). InFIG. 3 is illustrated an embodiment of the invention comprising thesignal generating member110 adapted to generate an audible and/or tactile and/or visible injection confirmation signal upon a performed medicament delivery, wherein the medicament delivery confirmation signal is generated when the drive means changes state from a pre-tensioned state wherein the first resilient member is pretensioned arranged within the plunger rod and the plunger rod is engaged to the tubular extension part, to a released state wherein the plunger rod is completely released from the tubular extension part and is no longer in contact with the signal generating member.
• FIG. 4a-FIG. 4cillustrates a side view and perspective views, respectively, of thesignal generating member110 according to an exemplary embodiment of the invention. In the illustrated embodiment, thesignal generating member110 is an elongated u-shaped bracket, provided with at least twoelongated arms111, directed in the proximal direction, and a lower part, a distal transversal end wall,112 directed in the distal direction of the medicament delivery device, when arranged within thetubular extension part22. Thesignal generating member110 may be made from metal, plastic, or any combination of these materials.
• FIG. 4cis a perspective, and partly exploded, view of thesignal generating member110 in relation to theplunger rod90 and the firstresilient member91. The upper parts of thearms111 are provided withangled support members113 extending in essentially radial outward directions with regard to a longitudinal axis of the u-bracket110. The u-bracket110 is adapted to enclose at least a part of theplunger rod90 and the firstresilient member91, and thesupport members113 are adapted to rest on an annular surface on the proximal end of thetubular extension part22 when the drive means are in a pre-tensioned state, i.e. theopening94 of theplunger rod90 is engage with a radial inward projected protrusion (not shown) of aflexible tongue121 of thetubular extension part22.
• When the drive means is in the pre-tensioned state, the distal end of the u-bracket110 is arranged at a predetermined distance “D” (seeFIG. 6a) from an inner distal surface of saidtubular extension part22 and when the drive means are in the released state, the distal end of the u-bracket110 is in contact with the inner distal surface of saidtubular extension part22. The audible and/or tactile and/or visible confirmation signal is generated when the distal end of the u-bracket110 hits and contacts the inner distal surface of thetubular extension part22 by a remaining force exerted by said firstresilient member91. Thus, during the delivery procedure, when the distal end of theplunger rod90 passes by the supportingmembers113, thearms111 with thesupport members113 are released and allowed to move in a radial inward direction, due to a pre-tension of thearms111, enabling the u-bracket110 to move in the distal direction and the signal, typically an audible sound and/or a visual signal and/or a tactile signal is generated, when the u-bracket110 hits the distal end of thetubular extension part22. In the pre-injection state the u-bracket110 is arranged such that thearms111 are positioned in a space along theplunger rod90 between theplunger rod90 and thetubular extension part22 enclosing theplunger rod90. Thesupport members113 must have an extension in the radial outward direction that exceeds the radial extension of the space between theplunger rod90 and the inner wall of thetubular extension part22 to secure that thesignal generating member110 is not released prior theplunger rod90 has moved away from between thearms111. the outer distal surface of the distaltransversal end wall112 may further have a protrusion (not illustrated), adapted to be guided through an opening, typically a through hole (also not illustrated) of the distal end wall of thetubular extension part22 and extends distally a predetermined distance over the outer surface of saidtubular extension part22. In an exemplary embodiment of the invention, the distally extending protrusion has a bright and/or different colour than the rest of the device for generating a visual signal. Thus, said protrusion will enable both a tactile and a visual signal when the u-bracket110 hits the distal end of thetubular extension part22.
• FIG. 5 illustrates the drive means as well as the holding means, wherein the holding means comprises thetubular operation member100 and thetubular extension part22. The above-mentioned first corresponding co-acting means35 are at least one inwards extending protrusion (seeFIG. 1b) on the distal end of the inner surface of thetubular activation member30 and the first co-acting means are at least onegroove101,102,103 on an outer surface of thetubular operation member100, such that said radial inwards extendingprotrusion35 is adapted to be guided within the at least onegroove101,102,103, forcing thetubular operation member100 to rotate when thetubular activation member30 is axially moved. A second co-acting means105 for holding theplunger rod90 and the firstresilient member91 in the pre-tensioned state comprises at least onegroove105 of thetubular operation member100 and engages with aflexible tongue121 on thetubular extension part22, which locks theplunger rod90 by the radial inwards extending protrusion (not shown) of theflexible tongue121 and engaging with theopening94 of theplunger rod90. When thetubular operation member100 is rotated, at least onegroove105 of thetubular operation member100 allows the radial inwards extending protrusion of theflexible tongue121 to radial extension, thereby releasing the engagement between the protrusion and theopening94 of theplunger rod90, thus releasing theplunger rod90, exerted by the force of the firstresilient member91, in a proximal direction.
• Themedicament delivery device1 further comprises a locking means interactively connected to thetubular activation member30. The locking means is preferably at least oneledge106 on an annular surface of thetubular operation member100 and a corresponding locking means are at least oneprotrusion95 on an outer surface of thetubular extension part22, such that said at least oneprotrusion95 is abutting said at least oneledge106 holding thetubular operation member100 rotable fixated to thetubular extension part22.
• FIG. 6a-FIG. 6cillustrates simplified side views of the distal part of themedicament delivery device1 according to the present invention. The purpose of these figures is to briefly describe and illustrate the important features required to achieve the stated objects. In the figures are shown thetubular extension part22 that partly encloses the drive means, i.e. theplunger rod90 and the firstresilient member91, and thesignal generating member110.
• InFIG. 6athemedicament delivery device1 is ready for use, wherein thesignal generating member110 is at a predetermined distance “D” from the inner distal surface of thetubular extension part22.
• InFIG. 6bthe delivery procedure is initiated and theplunger rod90 moves in the proximal direction forcing the slidable stopper83 (not shown) to expel the medicament via thedelivery member61. When the distal end of theplunger rod90 has passed the proximal part of thesignal generating member110 thearms111 of thesignal generating member110 flexes inwards allowing thesignal generating member110 to move in the distal direction, resulting in that a sound, and/or a tactile signal and/or a visual signal is generated when thesignal generating member110 contacts the inner distal surface of thetubular extension part22. This is illustrated byFIG. 6c.
• FIG. 7-FIG. 11 show side views along the longitudinal axis of themedical delivery device1. For sake of simplicity only features relevant for describing the signal generation are indicated; in addition some main parts of themedical delivery device1 are indicated inFIG. 7-FIG. 11.
• FIG. 7 shows the medicament delivery device in an initial state where thecap10 is still attached to the medicament delivery device. Thecontainer80 is arranged within the medicament delivery device having a predetermined volume of medicament and also provided with adelivery member61 and aslidable stopper83 at its distal end. The secondresilient member34 is arranged in the proximal end of the medicament delivery device applying a force to thetubular activation member30 in the proximal direction. Theplunger rod90 has a proximal end in contact with theslidable stopper83 and encloses, at least partly, the firstresilient member91 which is adapted to apply a force to theplunger rod90 in the proximal direction. The distal part of theplunger rod90 is arranged in thetubular extension part22 in combination with thesignal generating member110. In the most distal part of themedicament delivery device100 is indicated the distance “D”, i.e. the “sound-generating” distance between the distal part of thesignal generating member110 and the inner distal surface of thetubular extension part22.
• FIG. 8 shows the medicament delivery device in the final locked state, where thetubular activation member30 is locked in its proximal position, protecting thedelivery member61.
• FIG. 9 shows the medicament delivery device where thecap10 has been removed from the medicament delivery device resulting in that thetubular activation member30 is moved forward due to the forces exerted by the secondresilient member24. In the figure is shown in greater scale the proximal part of thesignal generating member110 and itssupport members113.
• FIG. 10 shows the medicament delivery device where thetubular activation member30 is forced in the distal direction resulting in that theplunger rod90 is released to be able to apply forces to theslidable stopper83 resulting in that the medicament is delivered. In the figure is shown in greater scale the proximal part of thesignal generating member110 and itssupport members113 and also the most distal part of the medicament delivery device.
• FIG. 11 shows the medicament delivery device where the delivery has been made. Theplunger rod90 has now forced theslidable stopper83 to expel all medicament from thecontainer80 through thedelivery member61. When the distal part of theplunger rod90 passes by the distal part of thesignal generating member110 thearms111 are allowed to move inwards due to the pre-tension of the arms (illustrated by the upper in-zoomed part) and thesignal generating member110 is released and moves thereby in the distal direction generating a signal, when reaching the distal end surface of the tubular extension part22 (illustrated by the lower in-zoomed part).
• Thus is illustrated asignal generating member110 provided with twoarms111. As indicated above, a higher number of arms is naturally possible within the scope of the present invention as defined by the appended claims. if a higher number of arms is considered, e.g. three or four, it is important that they all are pre-tensioned such that they exert radially inward directed forces and also that they are evenly distributed in a cross-sectional plane of thesignal generating member110 in order to securely hold drive means in the pre-tensioned state.
• With references mainly toFIG. 7 toFIG. 11 the operation of themedicament delivery device1 will now be described in more detail. In the pre-tensioned state, the at least oneprotrusion95 is abutting theledge106 and thegroove105 is not aligned with theflexible tongue121 that is preventing release of theplunger rod90. When thecap10 is removed themedicament delivery device1 is ready for use. Thetubular activation member30 is now in its most proximal position and themedicament delivery device1 is ready for use. Thetubular activation member30 is forced in the distal direction by the user and theprotrusion35 is moved along the groove fromposition101 to position102 achieving an anticlockwise rotation of thetubular operation member100, seen from the distal end. During the rotation of thetubular operation member100 theprotrusion95 is moved along theledge106 and finally comes off theledge106. Alignment ofgroove105 withflexible tongue121 enables the release of thepre-tensioned plunger rod90 to move in the proximal direction, by the force exerted by the firstresilient member91, and to apply forces to theslidable stopper83 that is forced to move in the proximal direction and the medicament is thus delivered. When the medicament has been delivered and the medicament delivery device is removed from the delivery site, thetubular activation member30 is forced in the proximal direction, by means of the secondresilient member34 and the locking means, e.g. a flexible tongue104 (seeFIG. 5), on the at least one groove of thetubular operation member100 which locks the radially inwards extendingprotrusion35 when the radially inwards extendingprotrusion35 is moved over thetongue104. Themedicament delivery device1 further comprises a locking means interactively connected to thetubular activation member30. The locking means is aflexible tongue104 on the at least one groove of thetubular operation member100 which locks the radially inwards extendingprotrusion35 when said radially inwards extendingprotrusion35 is moved over thetongue104.
• The generation of the signal functions as follows. When the drive means is in the pre-tensioned state, the distal end of the u-bracket110 is arranged at a predetermined distance “D” (seeFIG. 6a) from an inner distal surface of saidtubular extension part22 and when the drive means are in the released state, the distal end of the u-bracket110 is in contact with the inner distal surface of saidtubular extension part22. The audible and/or tactile and/or visible confirmation signal is generated when the distal end of the u-bracket110 hits and contacts the inner distal surface of thetubular extension part22 by a remaining force exerted by said firstresilient member91. Thus, during the delivery procedure, when the distal end of theplunger rod90 passes by the supportingmembers113, thearms111 with thesupport members113 are released and allowed to move in a radial inward direction, due to a pre-tension of thearms111, enabling the u-bracket110 to move in the distal direction and the signal, typically an audible sound and/or a visual signal and/or a tactile signal is generated, when the u-bracket110 hits the distal end of thetubular extension part22. In the pre-injection state the u-bracket110 is arranged such that thearms111 are positioned in a space along theplunger rod90 between theplunger rod90 and thetubular extension part22 enclosing theplunger rod90. Thesupport members113 must have an extension in the radial outward direction that exceeds the radial extension of the space between theplunger rod90 and the inner wall of thetubular extension part22 to secure that thesignal generating member110 is not released prior theplunger rod90 has moved away from between thearms111. the outer distal surface of the distaltransversal end wall112 may further have a protrusion (not illustrated), adapted to be guided through an opening, typically a through hole (also not illustrated) of the distal end wall of thetubular extension part22 and extends distally a predetermined distance over the outer surface of saidtubular extension part22. In an exemplary embodiment of the invention, the distally extending protrusion has a bright and/or different colour than the rest of the device for generating a visual signal. Thus, said protrusion will enable both a tactile and a visual signal when the u-bracket110 hits the distal end of thetubular extension part22.
• It is however to be understood that embodiments described above and shown in the drawings are to be regarded only as non-limiting examples of the present invention and that may be modified within the scope of the appended patent claims.

Claims (11)

1. A housing for a medicament delivery device comprising:

a proximal end;

a distal end;

an outer surface and an inner surface;

a cut-out located closer to the proximal end than the distal end, where the cut-out extends from the outer surface through to the inner surface to define a hole, where the cut-out has a frame that extends around the hole and protrudes radially outward from the outer surface.

2. The housing ofclaim 1 further comprising a thickness defined by the distance between the outer surface and the inner surface.

3. The housing ofclaim 2 where the cut-out further comprises side walls that project radially inward from the frame a distance greater than the thickness.

4. The housing ofclaim 1 where the frame defines an elongated oval.

5. The housing ofclaim 1 where the frame has two longitudinal sides and two circumferential

sides, where the longitudinal sides are of equal lengths that are parallel to a longitudinal axis of the housing, where the longitudinal sides are at least twice the length of the circumferential sides.

6. The housing ofclaim 1 where the hole allows visual observation of a container coaxially arranged within the housing.

7. The housing ofclaim 1 further comprising a second cut-out located 180 degrees from the cut-out, where the second cut-out is located closer to the proximal end than towards the distal end, where the second cut-out extends from the outer surface through to the inner surface to define a second hole, where the second cut-out has a second frame that extends completely around the second hole, where the second frame protrudes radially outward from the outer surface.

8. The housing ofclaim 5 where the two circumferential sides of the frame are shaped as half circles.

9. The housing ofclaim 1 where the frame extends completely around a periphery of the hole.

10. A medicament device comprising:

a housing having a proximal end, a distal end, an outer surface and an inner surface;

a container holder coaxially arranged within the housing and holding a medicament container containing medicament; and

a cut-out located closer to the proximal end than the distal end, where the cut-out extends from the outer surface through to the inner surface to define a hole, where the cut-out has a frame that extends around the hole and protrudes radially outward from the outer surface.

where the hole allows visual observation of the container coaxially arranged within the housing.

11. The medicament delivery device ofclaim 10 further comprises a drive positioned within the housing that generates a visual signal when the medicament is completely expelled from the medicament container.

Images